TRPC3 is Essential for Maintenance of Skeletal Muscle Cells  by Woo, Jin Seok & Lee, Eun Hui
Monday, February 22, 2010 343a[Ca2þ]o attenuates the amplitude of capsaicin (0.5 microM)-evoked single
channel currents through TRPV1 receptors within a physiologically relevant
concentration range (Kd ¼ 2 mM, Hill slope ¼ 1.1). The inhibition was ob-
served at a range of positive and negative membrane potentials, being more
pronounced at negative potentials. Use of patch clamp photometry revealed
that at60 mV in the presence of 10 mM [Ca2þ]o, which is almost maximally
effective for inhibiting single channel current amplitudes (56%), the fractional
of the current carried by Ca2þ current was only 40%. Thus, Naþ still carries
most of the cation current through the TRPV1 receptor even when Ca2þ is
likely occupying the site responsible for its inhibiting cation conductance. Fi-
nally, we observed that neutralizing the charge on single amino acids located
in the mouth of the putative pore and known to contribute to Ca2þ selection
by TRPV1 receptors, Asp646, Glu648 and Glu651, did not alter the inhibitory
effect of 2 mM [Ca2þ]o. To summarize, although Ca2þ has been reported to
increase the open probability of TRPV1 receptors, this divalent cation also at-
tenuates conductance through the channel pore via an unknown mechanism
seemingly discreet from that contributing to the high Ca2þ permeability of
these receptors.
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The capsaicin receptor (TRPV1) is a nonselective cation channel that integrates
multiple painful stimuli, including capsaicin, protons and heat. Protons facili-
tate the capsaicin- and heat -induced currents by decreasing thermal threshold
or increasing agonist potency for TRPV1 activation. In the presence of saturat-
ing capsaicin, rat TRPV1 (rTRPV1) reaches full activation, with no further
stimulation by protons. Human TRPV1 (hTRPV1), a species ortholog with
high homology to rTPRV1, is potentiated by extracellular protons and magne-
sium, even at saturating capsaicin. We investigated the structural basis for pro-
tons and magnesium modulation of fully capsaicin-bound human receptors. By
analysis of chimeric channels between hTRPV1 and rTRPV1,We mapped the
required domain and a single amino acid residue responsible for further poten-
tiation of capsaicin efficacy by protons. We also showed that magnesium ions
could also exert similar effects for capsaicin activation of human TRPV1, but
through a different functional domain. Our results demonstrate that capsaicin
efficacy of hTRPV1 correlates with the extracellular ion milieu, and unravel
the relevant structural basis of modulation by protons and magnesium.
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trameric TRPC6/C7 Channel Activity in Rabbit Portal Vein Myocytes
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Previously we have shown that synergism between inositol-1,4,5-trisphoshate
(IP3) and diacylglycerol (DAG) mediates activation of TRPC6-like channel
activity by noradrenaline (NA, Albert & Large, 2003) in rabbit portal vein my-
ocytes. Moreover, a recent study showed that endogenous phosphatidylinositol-
4,5-bisphosphate (PIP2) produced a marked inhibitory action on TRPC6 activ-
ity in mesenteric artery myocytes (Albert et al, 2008). In the present work we
investigated interactions between DAG, IP3 and PIP2 in regulating TRPC6-like
activity in portal vein myocytes using patch clamp and immunoprecipitation
methods.
In inside-out and cell-attached patches, bath application of respectively 10 mM
IP3 and the cell-permeable IP3 analogue, 10 mM 6-IP3, both potentiated OAG-
induced TRPC6-like channel activity by 3-fold but had no effect when applied
on their own. In inside-out patches, pre-treatment with 20 mM wortmannin, to
deplete endogenous PIP2 levels, increased OAG-evoked channel activity by 75-
fold compared to control patches. Moreover, anti-PIP2 antibodies activated
TRPC6-like activity in quiescent inside-out patches. In wortmannin-treated in-
side-out patches, 10 mM diC8-PIP2 inhibited OAG evoked channel activity
(IC50 ¼ 0.74 mM) which was rescued by over 50 % by co-application of
10 mM IP3. Anti-TRPC6 and anti-TRPC7 antibodies inhibited TRPC6-like
activity induced by NA by over 80%, but channel activity was unaffected by
other TRPC antibodies. Co-immunoprecipitation studies showed association
between TRPC6 and TRPC7 proteins and that both these channel proteins in-
teracted with PIP2. Pretreated with 6-IP3, reduced association between PIP2 and
TRPC7 but not TRPC6, whereas OAG reduced PIP2 interactions with TRPC6
but not TRPC7.
These results indicate that endogenous PIP2 has a pronounced inhibitory action
on TRPC6/TRPC7 heteromeric channels in portal vein myocytes. Moreover
channel activation by DAG requires both this triglyceride and IP3 to remove
associations between PIP2 and these channel proteins.1781-Pos
Isoform-Selective Physical Coupling of TRPC3 Channels to IP3 Receptors
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Many vasoconstrictors bind to phospholipase C (PLC)-coupled receptors on ar-
terial smooth muscle cells, leading to an intracellular inositol 1,4,5-trispho-
phate (IP3) elevation and vasoconstriction. IP3-induced vasoconstriction can
occur independently of intracellular Ca2þ release and via IP3 receptor (IP3R)
and canonical transient receptor potential (TRPC) channel activation, but sig-
naling mechanisms mediating this effect are unknown. Here, we studied the
mechanisms by which IP3Rs stimulate TRPC channels in smooth muscle cells
of resistance-size cerebral arteries. Immunofluorescence resonance energy
transfer (immuno-FRET) microscopy in smooth muscle cells indicated that en-
dogenous type 1 IP3Rs (IP3R1) are in close spatial proximity to TRPC3, but dis-
tant from TRPC6 or TRPM4 channels. Endothelin-1 (ET-1), a PLC-coupled re-
ceptor agonist, elevated the immuno-FRET signal between IP3R1 and TRPC3,
but not between IP3R1 and TRPC6 or TRPM4. IP3R1 co-immunoprecipitated
with TRPC3, but not with TRPC6. An antibody targeting TRPC3 channels and
TRPC3 channel knockdown with short hairpin RNA inhibited IP3-induced non-
selective cation current (ICat) activation, whereas an antibody to TRPC6 and
TRPC6 channel knockdown had no effect. Biotinylation indicated that ET-1
did not alter total or plasma membrane-localized TRPC3. RT-PCR demon-
strated that a calmodulin and IP3R binding (CIRB) domain is present on the
C-terminus of both TRPC3 and TRPC6 channels. A CIRB domain peptide at-
tenuated IP3- and ET-1-induced ICat activation. A peptide corresponding to the
IP3R region that can interact with TRPC channels activated ICat. A HIV-1 TAT-
conjugated CIRB domain peptide reduced IP3- and ET-1-induced vasoconstric-
tion in pressurized arteries. These data indicate that IP3 stimulates direct cou-
pling between IP3R1 and membrane-resident TRPC3 channels in arterial
smooth muscle cells, leading to ICat activation and vasoconstriction. Data
also indicate that close spatial proximity between IP3R1 and TRPC3 establishes
this isoform-selective functional interaction.
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The canonical transient receptor potential (TRPC) channels are widely distrib-
uted and have diverse biological functions. They are activated by stimulation of
phospholipase C-coupled receptors, resulting in membrane depolarization and
Ca2þ influx, which in turn feedback to regulate the channel activity through the
Ca2þ-binding protein calmodulin (CaM) and other signaling pathways. Previ-
ous biochemical studies indicate that TRPC subunits contain one to four puta-
tive CaM-binding sites. One of these sites is named the ‘‘CaM-IP3receptor
binding’’ or CIRB site (because it also interacts with an IP3 receptor fragment
in vitro). The CIRB site is conserved in all seven TRPC subunits. CaM exerts
either stimulatory or inhibitory effects on different TRPC channels. However,
the molecular mechanism of CaMmodulation of TRPC channels is unclear. We
have solved the crystal structure of the complex of CaM and the CIRB site of
TRPC5 channels, which regulate growth cone morphology and neurite growth,
and require CaM for agonist-induced activation. The structure shows that the
two lobes of a single Ca2þ-bound CaM (Ca2þ/CaM ) bind two CIRB peptides
arranged in parallel. This peptide dimerizes only in the presence of Ca2þ/CaM,
suggesting that Ca2þ/CaM binding to the CIRB site may induce major confor-
mational changes in intact channels. Structure-based mutagenesis studies show
that Ca2þ/CaM binding to the CIRB site is not required for agonist-induced
channel activation, but it safeguards the channel against inhibition produced
by CaM binding to another site on the channel. We have identified this inhib-
itory site and found it to be a novel CaM-binding motif that can interact with
not only Ca2þ/CaM but also CaM1234, a mutant CaM deficient in binding
Ca2þ. Our results provide new insights into the intricate feedback regulation
of a canonical TRP channel.
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During membrane depolarization associated with skeletal excitation-contrac-
tion (EC) coupling, L-type Ca2þ channels (dihydropyridine receptor
(DHPR) in the transverse (t)-tubule membrane) undergo conformational
changes that are transmitted to Ca2þ-release channel (ryanodine receptor
344a Monday, February 22, 2010type 1) in the sarcoplasmic reticulum (SR) causing Ca2þ release from the SR.
Canonical-type transient receptor potential cation channel 3 (TRPC3), an ex-
tracellular Ca2þ entry channel in the t-tubule and plasma membrane, is re-
quired for full-gain of skeletal EC coupling. The present study examined ad-
ditional role(s) for TRPC3 in skeletal muscle other than mediation of EC
coupling. We created a stable myoblast line (MDG/TRPC3 KD myoblast)
with reduced TRPC3 expression by knock-down of TRPC3 using retrovi-
rus-delivered small interference RNAs in a1SDHPR-null muscular dysgenic
myoblasts to eliminate any DHPR-mediated EC coupling-related events. Un-
like a1SDHPR-null muscular dysgenic myoblasts, MDG/TRPC3 KD myo-
blasts exhibited dramatic changes in cellular morphology (e.g., unusual ex-
pansion of both cell volume and the plasma membrane, and multi-nuclei)
and increased Ca2þ content in both the endoplasmic reticulum and cytoplasm
of resting myoblasts. Moreover, these myoblasts failed to differentiate into
myotubes. Therefore, TRPC3 in skeletal myoblasts is essential for mainte-
nance of skeletal muscle.
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TRPC channels have been identified as components of Ca2þ signaling path-
ways that promote maladaptive growth of the myocardium. Transgenic mice
over-expressing TRPC3 or 6 exhibited an increased propensity towards hyper-
trophic progression in response to pressure overload, in part through a Ca2þ-
dependent calcineurin-NFAT signaling pathway. Moreover, different TRPC
subunits are known to be up-regulated in heart failure and in hypertrophic
hearts after pressure overload. In this study we inhibited TRPC channel func-
tion with dominant negative (dn) TRPC mutants and examined the ensuing ef-
fect on cardiac hypertrophy and Ca2þ influx dynamics. One of these mutants
comprises an N-terminal TRPC4 fragment that we used to generate cardiac re-
stricted transgenic mice. Intracellular Ca2þ signals were measured in adult car-
diac myocytes of wildtype (WT) and dn-TRPC4 mice that underwent TAC
(transverse aortic banding) or a sham procedure. Isolated myocytes maintained
in Ca2þ-free buffer were store-depleted with CPA while being treated with
Ang II, followed by perfusion with Ca2þ containing buffer to analyze Ca2þ
influx with Fura-2 fluorescence. WT myocytes showed essentially no Ca2þ en-
try, however, hypertrophic myocytes that underwent TAC showed abundant
Ca2þ influx. SKF96365 inhibited this Ca2þ influx, suggesting a role for
TRPC channels. Indeed, isolated myocytes from dnTRPC4 transgenic mice
subjected to TAC lacked this Ca2þ influx, confirming that TRPC channels me-
diate this previously unrecognized influx activity associated with hypertrophy
in cardiac myocytes. Interestingly, Ca2þ transients from myocytes of dn-
TRPC4 mice showed increased peak amplitudes, which might indicate an in-
creased cardiac contractility and cardiac performance when dn-TRPC4 is ex-
pressed. More importantly, dnTRPC4 mice showed significant attenuation of
cardiac hypertrophy following TAC stimulation. These data show that inhibi-
tion of TRPC channels exerts ameliorative effects on the development of car-
diac hypertrophy by decreasing Ca2þ signals that likely regulate pro-hypertro-
phic pathways.
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Direct or indirect involvement of TRPC channels in store-operated Ca2þ entry
(SOCE) has repeatedly been proposed. In this study, we explored the role of
TRPC3 in SOCE-associated Ca2þ signaling of RBL-2H3 mast cells by employ-
ing both genetic and pharmacological strategies. Mast cells overexpressing
a fluorescence-tagged, functional TRPC3 fusion protein displayed enhanced
Ca2þ entry in a classical thapsigargin-induced store depletion/calcium re-entry
protocol. A well-characterized dominant-negative, n-terminal fragment of
TRPC3 (aa 1-302) reduced SOCE significantly down to basal entry. A similar
extent of inhibition was observed with a dominant negative mutant of Orai1
(E106Q). Two pore mutants of TRPC3 (E616K and E630Q), which represent
a non-functional, dominant negative protein and a protein with distinctly al-
tered cation permeability, respectively, failed to affect SOCE in RBL-2H3
cells. The pyrazol compound Pyr3 (ethyl-1-(4-(2,3,3-trichloroacrylamide)-
phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate), which was recently
proposed as a selective inhibitor of TRPC3 channels, effectively suppressed
SOCE in wild-type controls as well as TRPC3 over-expressing cells. Our re-sults argue against a role of TRPC3 as part of the store-operated Ca2þ perme-
ation pathway in RBL-2H3 cells and point towards an indirect link between
TRPC3 and SOCE.
Supported by the FWF project P18475 and P19820
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Myoblasts migration is a key step in myogenesis. It allows myoblasts alignment
and their fusion into myotubes. The process has been shown to involve m- or
m-calpains, two calcium-dependent cysteine proteases. Fluorometric measure-
ments of calpain activity in cultured cells showed a peak at the beginning of
the differentiation process. We also observed a concomitant and transient in-
crease of the influxofCa2þ and of the expression of TRPC1 protein. After repres-
sion of TRPC1 in myoblasts by siRNA and shRNA, this transient influx of
calcium was significantly reduced and the concomitant peak of calpain activity
was abolished. Interestingly, myoblasts fusion into myotubes was significantly
slowed down, due to a reduced speed of cell migration. Accordingly, migration
of control myoblasts was inhibited by 2 to 5 mMGsMT4 toxin, an inhibitor of
TRPchannels or by50mMZ-Leu-Leu, an inhibitor of calpain. These effectswere
not observed in TRPC1 knocked down cells. Moreover, TRPC1 knocked down
myoblasts also accumulated of myristoylated alanine-rich C-kinase substrate
(MARCKS), an actin-binding protein, substrate of calpain.We therefore suggest
that an entry of calcium through TRPC1 channels induces a transient activation
of calpain, a subsequent proteolysis ofMARCKS, allowing in its turn,myoblasts
migration and fusion. The role of TRPC1 in muscle regeneration, a process in-
volving myoblasts migration and differentiation, is under study.To further char-
acterize the role of TRPC1 inmuscle development, we comparedmorphological
and mechanical parameters of muscles from TRPC1þ/þ and TRPC1-/- mice. We
observed thatmuscles fromTRPC1-/-mice display a smaller fibre cross-sectional
area and generate less force per cross section area. They do not present other ma-
jor signs of myopathy but were more sensitive to muscle fatigue.
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Autosomal dominant polycystic kidney disease (ADPKD) is one of the most
common genetic diseases in human and is caused by mutations in PKD1 and
TRPP2 proteins. PKD1 (also known as polycystin-1 or PC1) is a large integral
membrane protein with 11 putative transmembrane regions, a large extracellu-
lar N terminus and a short intracellular C terminus. PKD1 is generally thought
to function as a cell surface receptor that couples extracellular stimuli to intra-
cellular signaling. TRPP2 (also known as polycystin-2, PKD2 or PC2) is
a member of the transient receptor potential (TRP) channel family. It has 6 pu-
tative transmembrane segments and a pore-forming loop and forms a Ca2þ-
permeable nonselective cation channel. How mutations in PKD1 and TRPP2
lead to ADPKD is unclear but these two proteins likely share some common
functions since mutations in them produce similar pathological manifestations.
These two proteins associate physically through their C-termini and form func-
tional complexes. However, the subunit composition of this complex and the
molecular mechanism of its assembly are unknown. By combining biochemis-
try, X-ray crystallography, and a single molecule imaging method to determine
the subunit composition of proteins in the plasma membrane of live cells, we
find that this complex contains 3 TRPP2 and 1 PKD1. A C-terminal coiled
coil domain of TRPP2 is critical for the assembly of this complex. This coiled
coil domain forms a homotrimer and binds to a single coiled coil domain in the
C-terminus of PKD1. Mutations that disrupt this coiled coil trimer abolish the
assembly of both full-length TRPP2 homotirmer and the TRPP2/PKD1 hetero-
meric complex, and diminish the surface expression of both proteins. These
finding have significant implications for the assembly, regulation and function
of the TRPP2/PKD1 complex, and for the pathogenic mechanism of some
ADPKD-producing mutations.
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